Unknown

Dataset Information

0

Increased levels of copeptin before clinical diagnosis of preeclampsia.


ABSTRACT: Copeptin, a surrogate biomarker of vasopressin, has been associated with renal function decline and may serve as a useful early biomarker for preeclampsia. We measured serum copeptin using samples collected longitudinally during pregnancy among unaffected controls (n=136) and cases of preeclampsia (n=169), gestational diabetes mellitus (n=92), gestational hypertension (n=101), and preterm birth (n=86) in the Calcium for Preeclampsia Prevention trial (1992-1995). Preeclampsia and gestational hypertension were defined as having a diastolic blood pressure?90 mm Hg on 2 occasions with and without proteinuria, respectively. The risk of pregnancy complications associated with copeptin was estimated by logistic regression adjusting for maternal age, race, body mass index, insurance status, marital status, current smoking, and clinical site. Baseline copeptin levels, at mean 16 weeks of gestation, were associated with increased preeclampsia risk (adjusted odds ratios and 95% confidence interval being 1.55 per log unit; 1.03-2.31) when compared with controls (P=0.03). The association was stronger among cases diagnosed before 37 weeks (1.86; 1.08-3.20) than those diagnosed later (1.45; 0.91-2.32). Copeptin levels rose with increasing gestational age in both cases and controls but remained significantly higher among those who were diagnosed with preeclampsia. Differences in levels of copeptin between cases and controls became more apparent closer to time of diagnosis. No significant associations were found for gestational hypertension without proteinuria, gestational diabetes mellitus, or preterm birth without preeclampsia. Copeptin levels are elevated in pregnant women before diagnosis of preeclampsia with elevation specific to this pregnancy complication rather than hypertension alone.

SUBMITTER: Yeung EH 

PROVIDER: S-EPMC6155480 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Increased levels of copeptin before clinical diagnosis of preeclampsia.

Yeung Edwina H EH   Liu Aiyi A   Mills James L JL   Zhang Cuilin C   Männistö Tuija T   Lu Zhaohui Z   Tsai Michael Y MY   Mendola Pauline P  

Hypertension (Dallas, Tex. : 1979) 20140915 6


Copeptin, a surrogate biomarker of vasopressin, has been associated with renal function decline and may serve as a useful early biomarker for preeclampsia. We measured serum copeptin using samples collected longitudinally during pregnancy among unaffected controls (n=136) and cases of preeclampsia (n=169), gestational diabetes mellitus (n=92), gestational hypertension (n=101), and preterm birth (n=86) in the Calcium for Preeclampsia Prevention trial (1992-1995). Preeclampsia and gestational hype  ...[more]

Similar Datasets

| S-EPMC4589375 | biostudies-literature
| S-EPMC8660865 | biostudies-literature
| S-EPMC8390481 | biostudies-literature
| S-EPMC7041089 | biostudies-literature
| S-EPMC4441670 | biostudies-literature
| S-EPMC4035325 | biostudies-literature
| S-EPMC6043369 | biostudies-literature
| S-EPMC6901393 | biostudies-literature
| S-EPMC8475051 | biostudies-literature
| S-EPMC6486846 | biostudies-literature